Horsetalk.co.nz - Full Article
July 25, 2017
Horsetalk.co.nz
A rider in Saudi Arabia has been suspended for a year and fined 2500 Swiss francs after his mount in a 110km endurance ride last January tested positive for phenylbutazone, oxyphenbutazone, and dexamethasone.
Ibrahim Abdulrahman Alsughayer rode the horse Nashmi Alghzlan in a CEI1* 110km race in Riyadh, Saudi Arabia, on January 14.
The horse was selected for testing, which revealed the presence of the three substances in the blood. Phenylbutazone and dyphenbutazone – a metabolic byproduct of phenylbutazone – are non-steroidal anti-inflammatory drugs with anti-inflammatory and painkilling effects. Dexamethasone is a corticosteroid drug with anti-inflammatory properties...
Read more at http://www.horsetalk.co.nz/2017/07/25/suspension-fine-endurance-horse-drug/#uO7Pb2PBHLwi5Lpd.99
Uruguay: Curious horse failed dope test after sharing groom’s ‘tea’
Horseandhound.co.uk - Full Article A recent FEI Tribunal case is a reminder to equestrians of the risk of accidental contamination By Lu...
-
Inside.fei.org 17 December 2020 The FEI Board took a series of key decisions on allocation, cancellation, and reopening of bids for FEI C...
-
Festival brings together the world’s leading endurance riders, placing Dubai at the centre of the global endurance calendar 19th edition ope... -
Equestrianists.com - Full Story Stevie Delahunt 20th February 2026 Hola, dot watchers!!! It’s been another day here in Patagonia, and w...
